These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 30083478

  • 1. CD80 and CTLA-4 as diagnostic and prognostic markers in adult-onset minimal change disease: a retrospective study.
    Zhao B, Han H, Zhen J, Yang X, Shang J, Xu L, Wang R.
    PeerJ; 2018; 6():e5400. PubMed ID: 30083478
    [Abstract] [Full Text] [Related]

  • 2. Toll-like receptor 3 (TLR-3), TLR-4 and CD80 expression in peripheral blood mononuclear cells and urinary CD80 levels in children with idiopathic nephrotic syndrome.
    Mishra OP, Kumar R, Narayan G, Srivastava P, Abhinay A, Prasad R, Singh A, Batra VV.
    Pediatr Nephrol; 2017 Aug; 32(8):1355-1361. PubMed ID: 28210837
    [Abstract] [Full Text] [Related]

  • 3. Minimal change disease: a dysregulation of the podocyte CD80-CTLA-4 axis?
    Cara-Fuentes G, Wasserfall CH, Wang H, Johnson RJ, Garin EH.
    Pediatr Nephrol; 2014 Dec; 29(12):2333-40. PubMed ID: 25017621
    [Abstract] [Full Text] [Related]

  • 4. Urinary CD80 excretion increases in idiopathic minimal-change disease.
    Garin EH, Diaz LN, Mu W, Wasserfall C, Araya C, Segal M, Johnson RJ.
    J Am Soc Nephrol; 2009 Feb; 20(2):260-6. PubMed ID: 19056875
    [Abstract] [Full Text] [Related]

  • 5. Usefulness of the cytokines expression of Th1/Th2/Th17 and urinary CD80 excretion in adult-onset minimal change disease.
    Chen P, Chen Y, Jiang M, Mo Y, Ying H, Tang X, Zhang J.
    PeerJ; 2020 Feb; 8():e9854. PubMed ID: 33194357
    [Abstract] [Full Text] [Related]

  • 6. Urinary CD80 Discriminates Among Glomerular Disease Types and Reflects Disease Activity.
    Gonzalez Guerrico AM, Lieske J, Klee G, Kumar S, Lopez-Baez V, Wright AM, Bobart S, Shevell D, Maldonado M, Troost JP, Hogan MC, Nephrotic Syndrome Study Network Consortium (NEPTUNE).
    Kidney Int Rep; 2020 Nov; 5(11):2021-2031. PubMed ID: 33163723
    [Abstract] [Full Text] [Related]

  • 7. Urinary CD80 as a Replacement for Renal Biopsy for Diagnosis of Pediatric Minimal Change Disease.
    Ahmed HM, Ezzat DA, Doudar NA, Adel M.
    Iran J Kidney Dis; 2018 Mar; 12(2):107-111. PubMed ID: 29507273
    [Abstract] [Full Text] [Related]

  • 8. Urinary CD80 levels as a diagnostic biomarker of minimal change disease.
    Ling C, Liu X, Shen Y, Chen Z, Fan J, Jiang Y, Meng Q.
    Pediatr Nephrol; 2015 Feb; 30(2):309-16. PubMed ID: 25142334
    [Abstract] [Full Text] [Related]

  • 9. CD80 expression and infiltrating regulatory T cells in idiopathic nephrotic syndrome of childhood.
    Eroglu FK, Orhan D, İnözü M, Duzova A, Gulhan B, Ozaltin F, Topaloglu R.
    Pediatr Int; 2019 Dec; 61(12):1250-1256. PubMed ID: 31513327
    [Abstract] [Full Text] [Related]

  • 10. Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis.
    Garin EH, Mu W, Arthur JM, Rivard CJ, Araya CE, Shimada M, Johnson RJ.
    Kidney Int; 2010 Aug; 78(3):296-302. PubMed ID: 20485332
    [Abstract] [Full Text] [Related]

  • 11. Cytotoxic T- Lymphocyte Antigen-4 (CTLA4) Gene Expression and Urinary CTLA4 Levels in Idiopathic Nephrotic Syndrome.
    Mishra OP, Chhabra P, Narayan G, Srivastava P, Prasad R, Singh A, Abhinay A, Batra VV.
    Indian J Pediatr; 2019 Jan; 86(1):26-31. PubMed ID: 29968132
    [Abstract] [Full Text] [Related]

  • 12. Urinary CD80: a biomarker for a favorable response to corticosteroids in minimal change disease.
    Cara-Fuentes G, Lanaspa MA, Garcia GE, Banks M, Garin EH, Johnson RJ.
    Pediatr Nephrol; 2018 Jul; 33(7):1101-1103. PubMed ID: 29492674
    [Abstract] [Full Text] [Related]

  • 13. Urinary soluble HLA class I antigen in patients with minimal change disease: a predictor of steroid response.
    Park CW, Song HC, Shin YS, Ahn SJ, Kim YS, Kim SY, Choi EJ, Chang YS, Bang BK.
    Nephron; 1998 Jul; 79(1):44-9. PubMed ID: 9609461
    [Abstract] [Full Text] [Related]

  • 14. CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance.
    Cara-Fuentes G, Wei C, Segarra A, Ishimoto T, Rivard C, Johnson RJ, Reiser J, Garin EH.
    Pediatr Nephrol; 2014 Aug; 29(8):1363-71. PubMed ID: 24263531
    [Abstract] [Full Text] [Related]

  • 15. Urinary CD80 and Serum suPAR as Biomarkers of Glomerular Disease among Adults in Brazil.
    Zen RC, Dominguez WV, Braga I, Dos Reis LM, Jorge LB, Yu L, Woronik V, Dias CB.
    Diagnostics (Basel); 2023 Jan 05; 13(2):. PubMed ID: 36673014
    [Abstract] [Full Text] [Related]

  • 16. CD80 Insights as Therapeutic Target in the Current and Future Treatment Options of Frequent-Relapse Minimal Change Disease.
    Teh YM, Lim SK, Jusoh N, Osman K, Mualif SA.
    Biomed Res Int; 2021 Jan 05; 2021():6671552. PubMed ID: 33506028
    [Abstract] [Full Text] [Related]

  • 17. Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis.
    Garin EH, Reiser J, Cara-Fuentes G, Wei C, Matar D, Wang H, Alachkar N, Johnson RJ.
    Pediatr Nephrol; 2015 Mar 05; 30(3):469-77. PubMed ID: 25239302
    [Abstract] [Full Text] [Related]

  • 18. Treatment of the idiopathic nephrotic syndrome: regimens and outcomes in children and adults.
    Tune BM, Mendoza SA.
    J Am Soc Nephrol; 1997 May 05; 8(5):824-32. PubMed ID: 9176855
    [Abstract] [Full Text] [Related]

  • 19. Long-term results of cyclosporine-induced remission of relapsing nephrotic syndrome in children.
    Kim PK, Kim KS, Pai KS, Kim JH, Choi IJ.
    Yonsei Med J; 1997 Oct 05; 38(5):307-18. PubMed ID: 9409194
    [Abstract] [Full Text] [Related]

  • 20. Serum from minimal change patients in relapse increases CD80 expression in cultured podocytes.
    Ishimoto T, Cara-Fuentes G, Wang H, Shimada M, Wasserfall CH, Winter WE, Rivard CJ, Araya CE, Saleem MA, Mathieson PW, Johnson RJ, Garin EH.
    Pediatr Nephrol; 2013 Sep 05; 28(9):1803-12. PubMed ID: 23689904
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.